TOMI Environmental Solutions, Inc. announces a collaboration with SixLog Corporation, a worldwide biological decontamination and sterilization services company using SteraMist Environment Units.
SixLog Corporation, a sterilization division of parent company Astro Pak Corporation, recently placed an order for 10 SteraMist Environment Units. SixLog is registered and licensed by the California EPA Department of Pesticide Regulation. SixLog and Astro Paks CFO, Ken Carroll, says, Having researched potential technologies, we have extended our collaboration with TOMIs novel SteraMist technology powered by Binary Ionization Technology® to be used by our service teams with our overall goal to help safeguard the environment in the life and health sciences companies that contract with SixLog.
Dr. Halden Shane, TOMIs CEO, notes, This purchase order from a repeat customer is a great way to move into the new year and accelerate our expansion strategy so as to allow us to build more shareholder value.
The TOMI technology is a decontamination system that applies cold plasma activation to a low percentage hydrogen peroxide-based aerosol, which then produces a Reactive Oxygen Species (ROS) mist that deactivates organic compounds and quickly inactivates viruses and bacteria including bacterial spores (C. diff) as well as mold spores, other fungi and yeast, both in the air and on surfaces. SteraMist leaves no residue or noxious fumes, provides fast-acting, broad-spectrum decontamination and is environmentally friendly and is safe for delicate medical equipment and computers.
Source: TOMI Environmental Solutions, Inc.
The Role of Environmental Hygiene in Preventing Antimicrobial Resistance
March 19th 2024Uncover the pivotal role of environmental hygiene in thwarting antimicrobial resistance (AMR) for infection prevention teams. Learn how rigorous cleaning protocols and advanced technologies enhance patient safety and combat AMR.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.